Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05641961

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Utilizing a Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.

Detailed description

PRIMARY OBJECTIVE: I. To determine the difference in survivor/caregiver knowledge and understanding of diagnosis, treatment information, and follow-up needs using the survivorship app. SECONDARY OBJECTIVE: I. To validate the usability and effectiveness of the survivorship mobile application. OUTLINE: Participants are seen in the survivorship clinic and receive education about potential late effects and the survivorship application on study. Participants then use the survivorship app for 4 months on study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSurvivorship mobile applicationMobile phone application
OTHERQuestionnairesQuestionnaires assessing cancer knowledge and system usability will be delivered to participants via Survivorship App

Timeline

Start date
2022-11-29
Primary completion
2026-04-30
Completion
2026-04-30
First posted
2022-12-08
Last updated
2025-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05641961. Inclusion in this directory is not an endorsement.